However, EGFR-TKI resistance or T790M mutation in carcinoma cells itself could induce p22phox and the status of p22phox in LUAD tissues without T790M mutation was by no means correlated with any of the clinicopathological factors examined. Here, EGFR is linked to carcinoma.